Literature DB >> 21818569

Evaluation of organ-specific glucose metabolism by ¹⁸F-FDG in insulin receptor substrate-1 (IRS-1) knockout mice as a model of insulin resistance.

Chao Cheng1, Akinobu Nakamura, Ryogo Minamimoto, Kazuaki Shinoda, Ukihide Tateishi, Atsushi Goto, Takashi Kadowaki, Yasuo Terauchi, Tomio Inoue.   

Abstract

OBJECTIVE: Insulin resistance (IR) is a physiological condition in which the body produces insulin but does not result in a sufficient biological effect. Insulin resistance is usually asymptomatic but is associated with health problems and is a factor in the metabolic syndrome. The aim of the present study is to clarify organ-specific insulin resistance in normal daily conditions using [(18)F]-2-fluoro-2-deoxy-D: -glucose ([(18)F]-FDG).
METHODS: The biodistribution of [(18)F]-FDG was examined in insulin receptor substrate-1 (IRS-1) knockout mice, an animal model of skeletal muscle insulin resistance, and C57BL/6J (wild-type) mice with and without insulin loading. Mice received 0.5 MBq of [(18)F]-FDG injected into the tail vein, immediately followed by nothing (control cohorts) or an intraperitoneal injection of 1.5 mU/g body weight of human insulin as an insulin loading test. Blood glucose concentrations for all of the experimental animals were assessed at 0, 20, 40, and 60 min post-injection. The mice were subsequently killed, and tissue was collected for evaluation of [(18)F]-FDG biodistribution. The radioactivity of each organ was measured using a gamma counter.
RESULTS: In the absence of insulin, the blood glucose concentrations of wild-type mice (132 ± 26 mg/dl) and IRS-1 knockout mice (134 ± 18 mg/dl) were not significantly different. Blood glucose concentrations decreased following insulin administration, with lower concentrations in wild-type mice than in knockout mice at 20, 40, and 60 min. A statistically significant difference in [(18)F]-FDG uptake between wild-type mice and IRS-1 knockout mice was confirmed in the heart, abdominal muscle, and femoral muscle. With insulin loading, [(18)F]-FDG uptake in the heart, back muscle, and abdominal muscle was significantly increased compared to without insulin loading in both wild-type mice and knockout mice.
CONCLUSION: Our results showed that IR significantly affected [(18)F]-FDG uptake in the heart in normal daily conditions. IR was associated with decreased [(18)F]-FDG uptake in the heart and was readily observed in the absence of insulin loading. [(18)F]-FDG-positron emission tomography (PET) could be a useful tool for evaluating insulin resistance in images by investigating tissue-specific differences in [(18)F]-FDG uptake.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21818569     DOI: 10.1007/s12149-011-0522-y

Source DB:  PubMed          Journal:  Ann Nucl Med        ISSN: 0914-7187            Impact factor:   2.668


  3 in total

1.  Fpr2 Deficiency Alleviates Diet-Induced Insulin Resistance Through Reducing Body Weight Gain and Inhibiting Inflammation Mediated by Macrophage Chemotaxis and M1 Polarization.

Authors:  Xiaofang Chen; Shu Zhuo; Tengfei Zhu; Pengle Yao; Mengmei Yang; Hong Mei; Na Li; Fengguang Ma; Ji Ming Wang; Shiting Chen; Richard D Ye; Yu Li; Yingying Le
Journal:  Diabetes       Date:  2019-03-12       Impact factor: 9.461

2.  FDG uptake tracks the oxidative damage in diabetic skeletal muscle: An experimental study.

Authors:  Matteo Bauckneht; Vanessa Cossu; Patrizia Castellani; Patrizia Piccioli; Anna Maria Orengo; Laura Emionite; Francesco Di Giulio; Maria Isabella Donegani; Alberto Miceli; Stefano Raffa; Anna Borra; Selene Capitanio; Silvia Morbelli; Giacomo Caviglia; Silvia Bruno; Silvia Ravera; Davide Maggi; Gianmario Sambuceti; Cecilia Marini
Journal:  Mol Metab       Date:  2019-11-15       Impact factor: 7.422

3.  Evaluation of organ glucose metabolism by 18F-FDG accumulation with insulin loading in aged mice compared with young normal mice.

Authors:  Jingmin Zhao; Chengbo Tan; Ryota Imai; Naoyuki Ukon; Saki Shimoyama; Yuko Maejima; Yuji Omiya; Kazuhiro Takahashi; Hiroshi Ito; Guangxian Nan; Songji Zhao; Kenju Shimomura
Journal:  Sci Rep       Date:  2021-04-01       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.